BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Anlon Healthcare Ltd

Chemicals

Offer Period :

26th to 29th Aug 2025

Anlon Healthcare Ltd IPO Details

IPO Date 26th to 29th Aug 2025 Minimum Investment ₹14924 / 1 Lots
Listing Date 2025-09-03 Maximum Investment ₹194012 / 13 Lots
Face Value ₹10 per share Total Issue Size ₹121.03 Crores
Price ₹91 to ₹91 per share Fresh Issue ₹121.03 Crores
Lot Size 1 Lots (164 Shares) Offer For Sale ₹ [-]
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹0 per Share Shareholding Pre Issue 39851500 Shares
Issue Type Book Building Shareholding Post Issue 53151500 Shares
IPO Date 26th to 29th Aug 2025
Listing Date 2025-09-03
Face Value ₹10 per share
Price ₹91 to ₹91 per share
Lot Size 1 Lots (164 Shares)
Listing At BSE, NSE
Total Issue Size ₹121.03 Crores
Employee Discount ₹0 per share
Issue Type Book Building
Minimum Investment ₹14924 / 1 Lots
Maximum Investment ₹194012 / 13 Lots
Fresh Issue ₹121.03 Crores
Offer For Sale ₹[-] Crores
Retail Discount ₹0 Crores
Shareholding Pre Issue 39851500 Shares
Shareholding Post Issue 53151500 Shares

About Anlon Healthcare Ltd IPO

Incorporated in 2013, Anlon Healthcare Limited is engaged in the manufacturing of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company’s operations focus on producing high-purity intermediates for API production and APIs used in formulations for medicines, nutraceuticals, personal care, and animal health products. Its portfolio spans sixty-five commercialised products, twenty-eight at the pilot stage, and forty-nine undergoing laboratory testing. The company manufactures as per Indian and international pharmacopeia standards including IP, BP, EP, JP, and USP, ensuring regulatory compliance across different markets.

Beyond its established product lines, Anlon Healthcare also provides custom manufacturing services for complex chemicals, designed to achieve higher purity and meet client-specific requirements. The company has filed 21 Drug Master Files (DMFs) with global authorities and holds approvals for APIs such as loxoprofen sodium dihydrate and loxoprofen acid, while also pursuing approvals for Ketoprofen and Dexketoprofen Trometamol. With four laboratories and a team of 34 members, including 24 science graduates, the company integrates testing, analysis, and process improvements to support its research, production, and quality assurance.

Founding Year: 2013

Managing Director: Punitkumar R Rasadia

Anlon Healthcare Limited Timeline

Important dates for allocation and IPO listing.

26th Aug

IPO Opens

29th Aug

IPO Close

1st Sep

Allotment Date

2nd Sep

Initiation of Refund

2nd Sep

Credit of Shares to Demat Account

3rd Sep

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 70.26 52.68
Public Group 29.74 47.32

Anlon Healthcare Ltd IPO Reservation

QIB Shares Offered 3990000(30%)
NII (HNI) Shares Offered 1995000(15%)
Retail Shares Offered 1330000(10%)
Anchor Investor Shares Offered 5985000(45%)
Total Shares Offered 13300000
Total Shares With Anchor Investor 13300000

Anlon Healthcare Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 164 ₹14924
Retail (Max) 13 2132 ₹194012
S HNI (Min) 14 2296 ₹208936
S HNI (Max) 67 10988 ₹999908
B HNI (MIN) 68 11152 ₹1014832

Anlon Healthcare Ltd IPO Anchor Investor Details

Bid Date 25 August 2025
Shares Offered 0
Anchor Portion Size 0

Anlon Healthcare Ltd IPO Registrar

KFin Techologies Ltd
Phone Number +91 40 6716 2222
Email Id einward.ris@kfintech.com
Our Website www.kfintech.com

Anlon Healthcare Ltd IPO Lead Manager

1. Interactive Financial Services Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Anlon Healthcare Ltd Financial Information

Period Ended March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹80.42 ₹21.03 ₹7.37
Reserves and Surplus ₹40.57 ₹5.03 ₹-4.63
Total Borrowing ₹58.35 ₹74.56 ₹66.39

Anlon Healthcare Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 9975000 10689028 1.0716
Non Institutional Investors (NIIs) 1995000 21161412 10.6072
NII(Bid amount of more than Ten Lakh Rupees) 1330000 10059924 7.5639
NII(Bid amount of more than 2 Lakh < 10 Rupees) 665000 11101488 16.694
Retail Individual Investors (RIIs) 1330000 62889080 47.285
Total 13300000 94739520 7.1233

Strength of Anlon Healthcare Ltd

1. Strong product portfolio of more sixty-five (65) commercialised products, twenty-eight (28) products at pilot stage, forty-nine (49) products at lab testing stage.

2. Scalable business model.

3. Established customer base.

4. Operating in high entry and exit barriers due to long customer approval cycles and strict product standards.

5. In-house testing, QA / QC for quality control of the product portfolio.

6. Experienced Promoters and Management Team.

Risks Involved

1. The company is subject to stringent quality specifications and regular customer audits. Non-compliance may result in order cancellations, warranty claims, or reputational damage. In the past, its manufacturing facility was non-operational for a period of four (4) months to address certain directions and recommendations issued by the Brazilian Health Regulatory Agency, which temporarily halted the company manufacturing operations.

2. Any failure to maintain product quality or comply with evolving quality standards may lead to customer dissatisfaction, loss of business, and legal liability.

3. The company has a limited operating history in manufacturing.

4. In the past, the company Manufacturing Facility remained non-operational for a period of four (4) months, resulting in a halt in its manufacturing capabilities. Any future event that causes a temporary or prolonged shutdown of the company Manufacturing Facility could significantly impact its production capacity, disrupt the copmpany supply chain, and adversely affect its business operations.

5. The Company is yet to place orders for the equipment, plant and machinery for the expansion of the Manufacturing Facility. Any delay in placing orders or procurement of such equipment, plant and machinery may delay the schedule of implementation and possibly increase the cost of commencing operations.

6. The company is products are exposed to risks of contamination, adulteration, and tampering during manufacturing, storage, or transit, which may adversely impact product quality, lead to regulatory non-compliance, and result in reputational and financial loss.

7. The company exposed to risks of product recalls and liability claims, which may involve significant costs, reputational harm, and regulatory consequences.

8. Its revenue from operations is dependent upon a limited number of customers and the loss of any of these customers or loss of revenue from any of these customers could have a material adverse effect on the company business, financial condition, results of operations and cash flows.

9. Its derive majority of the company revenue from the sale of its products to various segments of pharmaceutical Industry and any reduction in demand for the company customer products, or if such products become obsolete due to a breakthrough in the development of alternate drugs, could have an adverse effect on the company business.

10. Comparison of the comapny valuation multiples with peer companies may highlight potential investment risks.

Why should you invest in

-

Anlon Healthcare Ltd Financials

Particulars For the financial year ending (in ₹ million)
 
Total Assets
Total Liabilities
Total Expenses
Total Revenue 
Profit After Tax
EBITDA
Adjusted EBITDA

Anlon Healthcare Limited IPO Contact Details

Anlon Healthcare Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2025-09-03 544497 AHCL
INE0Y8W01017
₹91 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹91 ₹91
Open ₹0 ₹0
Low ₹0 ₹0
High ₹0 ₹0
Low ₹0 ₹0

Industry Outlook of Anlon Healthcare IPO

  • India holds a significant position in the global generic drug manufacturing space, contributing to the growth of the pharmaceutical industry.

  • The expiry of patents on various global drugs has created opportunities for Indian companies to produce affordable generic versions.

  • By leveraging this, Indian pharmaceutical firms have been able to supply cost-effective alternatives to international markets.

  • The sector recorded a compound annual growth rate (CAGR) of 9.9% between FY 2019 and FY 2024.

  • Turnover rose from INR 2,585 billion in FY 2019 to an estimated INR 4,142 billion in FY 2024.

  • Companies have also been expanding their reach beyond domestic markets.

  • Strategic acquisitions and collaborations have supported this global expansion.

  • Adherence to international quality and regulatory standards has played a role in boosting exports.

  • These factors have collectively strengthened revenue generation for Indian pharmaceutical firms.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Anlon Healthcare IPO.

Frequently Asked Questions

What is Anlon Healthcare Ltd IPO?

Answer Field

Anlon Healthcare Ltd IPO is a Mainboard IPO of 1,33,00,000 equity shares of a face value of ₹10 aggregating up to ₹121.03 Crores. The issue is priced at ₹91 to ₹91 per share. The minimum order quantity is 164 Shares. The IPO opens on August 26, 2025, and closes on August 29, 2025. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Anlon Healthcare Ltd IPO will open?

Answer Field

The Anlon Healthcare Ltd IPO opens on August 26, 2025 and closes on August 29, 2025.

What is the lot size of Anlon Healthcare Ltd?

Answer Field

Anlon Healthcare Ltd lot size is 164 shares, and the minimum amount required is ₹14,924.

How to apply for Anlon Healthcare Ltd IPO?

Answer Field

You can apply in Anlon Healthcare Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Anlon Healthcare Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Anlon Healthcare Ltd IPO will be done on September 01, 2025, and the allotted shares will be credited to your demat account by September 02, 2025.

When is Anlon Healthcare Ltd IPO listing date?

Answer Field

The Anlon Healthcare Ltd listing date is September 03, 2025.

Who is the registrar of Anlon Healthcare Ltd IPO?

Answer Field

The registrar of Anlon Healthcare Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Interactive Financial Services Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Anlon Healthcare Ltd IPO?

Answer Field

The fresh issue size is ₹121.03 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Anlon Healthcare Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 164 shares and ₹14,924 amount.

How can I approve the UPI mandate request for Anlon Healthcare Ltd IPO?

Answer Field

To apply for Anlon Healthcare Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Anlon Healthcare Ltd?

Answer Field

The price of each Anlon Healthcare Ltd share will be ranging in between ₹91 to ₹91 per share.

What is the cut-off time for the UPI mandate for Anlon Healthcare Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, August 29, 2025.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text